DURECT Reports Data From European Phase IIb Hysterectomy Study of Posidur (SABER-Bupivacaine) »
CUPERTINO, Calif., June 16 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine... …
Jun 17 2010 / Comments Off / Read More »Abbott Vascular Lays Off Workers »
Abbott Vascular Lays Off Workers [The Press-Enterprise, Riverside, Calif.] From Press-Enterprise (Riverside, CA) (June 17, 2010) Jun. 17--Abbott Vascular, Temecula’s largest private employer and a division of Abbott Laboratories, has laid... …
Jun 17 2010 / Comments Off / Read More »Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals »
LAKE FOREST, Ill., June 17 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP) , a global specialty pharmaceutical and medication delivery company, today announced a further extension of the tender offer by Discus Acquisition Corporation, a…
Jun 17 2010 / Comments Off / Read More »FDA Advisory Committee Recommended US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes »
WILMINGTON, DE – July 28, 2010 – AstraZeneca today announced that the US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs…
Jul 29 2010 / Comments Off / Read More »FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis »
Darmstadt, Germany, July 28, 2010 - Merck KGaA announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing…
Jul 28 2010 / Comments Off / Read More »Tibotec Pharmaceuticals Submits New Drug Application for Investigational Once-Daily HIV Treatment TMC278 to U.S. Food and Drug Administration »
TITUSVILLE, N.J., July 26 /PRNewswire/ -- Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food…
Jul 26 2010 / Comments Off / Read More »